Insider · CIK 0002018686
Prakash Raman
director
Files at BDTX (Black Diamond Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +6,801 | $1.93 | $13k | 51,840 | 21 d ago |
| Dec 12, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +4,665 | $2.76 | $13k | 31,027 | Dec 15, 2025 |
| Sep 19, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +3,843 | $3.35 | $13k | 26,362 | Sep 22, 2025 |
| Jun 20, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +5,526 | $2.33 | $13k | 22,519 | Jun 20, 2025 |
| Jun 12, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,550 | $0.00 | $0 | 30,550 | Jun 12, 2025 |
| Mar 21, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +6,848 | $1.88 | $13k | 16,993 | Mar 21, 2025 |
| Dec 13, 2024 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +5,150 | $2.50 | $13k | 10,145 | Dec 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.